Matches in Nanopublications for { ?s ?p "[In this study, we investigated the antitumor activity of a small-molecule survivin suppressant YM155 alone and in combination with alemtuzumab in a murine model of human ATL (MET-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_assertion description "[In this study, we investigated the antitumor activity of a small-molecule survivin suppressant YM155 alone and in combination with alemtuzumab in a murine model of human ATL (MET-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_provenance.
- assertion description "[In this study, we investigated the antitumor activity of a small-molecule survivin suppressant YM155 alone and in combination with alemtuzumab in a murine model of human ATL (MET-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In this study, we investigated the antitumor activity of a small-molecule survivin suppressant YM155 alone and in combination with alemtuzumab in a murine model of human ATL (MET-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP440832.RAxfcUdSi3KkMdGH-If13HZwmNXh-03RnHk4kFv6h6SA8130_assertion description "[In this study, we investigated the antitumor activity of a small-molecule survivin suppressant YM155 alone and in combination with alemtuzumab in a murine model of human ATL (MET-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440832.RAxfcUdSi3KkMdGH-If13HZwmNXh-03RnHk4kFv6h6SA8130_provenance.
- NP442755.RAYZQd-Tl1_p7YBKvjImnmcTZ1weD0zY_OonbXo6EILis130_assertion description "[In this study, we investigated the antitumor activity of a small-molecule survivin suppressant YM155 alone and in combination with alemtuzumab in a murine model of human ATL (MET-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442755.RAYZQd-Tl1_p7YBKvjImnmcTZ1weD0zY_OonbXo6EILis130_provenance.
- NP442758.RAs7gk6JcIsxKyV2ELHqVpJy8Set8nxc2tbIcxdjCEPS8130_assertion description "[In this study, we investigated the antitumor activity of a small-molecule survivin suppressant YM155 alone and in combination with alemtuzumab in a murine model of human ATL (MET-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442758.RAs7gk6JcIsxKyV2ELHqVpJy8Set8nxc2tbIcxdjCEPS8130_provenance.
- NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_assertion description "[In this study, we investigated the antitumor activity of a small-molecule survivin suppressant YM155 alone and in combination with alemtuzumab in a murine model of human ATL (MET-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_provenance.
- NP1044097.RA_2GBUZSIx31yUDFRuV77L9gq6M8nMtXv8TAzaYYMvqE130_assertion description "[In this study, we investigated the antitumor activity of a small-molecule survivin suppressant YM155 alone and in combination with alemtuzumab in a murine model of human ATL (MET-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1044097.RA_2GBUZSIx31yUDFRuV77L9gq6M8nMtXv8TAzaYYMvqE130_provenance.